Bristol Myers Squibb (BMY) Income towards Parent Company (2009 - 2026)
Bristol Myers Squibb's Income towards Parent Company came in at $3.32 billion for Q2 2026, up 153.2% from $1.31 billion a year earlier and up 23.9% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Income towards Parent Company (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bristol Myers Squibb reported Income towards Parent Company of $9.28 billion, up 83.8% year-over-year; for FY2025, it came in at $7.05 billion.
- Going back by year, Income towards Parent Company was -$8.95 billion in FY2024, $8.03 billion in FY2023 (+26.8%), $6.33 billion in FY2022 (-9.5%) and $6.99 billion in FY2021.
- The Q2 2026 figure represents the highest quarterly Income towards Parent Company since Q4 2009.
- Year-over-year, Income towards Parent Company increased in three of the last six quarters, with growth averaging 14.8%.
- The fastest year-over-year change in Income towards Parent Company over five years came in Q2 2026 (growth of 153.2%), and the weakest in Q4 2024 (a decline of 95.9%).
- Business Quant data shows BMY's Income towards Parent Company at $2.68 billion (Q1 2026), $1.09 billion (Q4 2025) and $2.2 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Bristol Myers Squibb | 125.59 Bn | 76.86 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.32 Bn |
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 72.00 Mn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | -11.91 Bn |
| Dec 31, 2023 | 1.76 Bn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.07 Bn |
| Mar 31, 2023 | 2.26 Bn |
| Dec 31, 2022 | 2.02 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.42 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 1.55 Bn |
API Access
Bristol Myers Squibb Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();